Workflow
Adient (ADNT) Q1 Earnings and Revenues Top Estimates
ADNTAdient(ADNT) ZACKS·2025-01-28 14:00

Company Performance - Adient reported quarterly earnings of 0.27pershare,exceedingtheZacksConsensusEstimateof0.27 per share, exceeding the Zacks Consensus Estimate of 0.24 per share, but down from 0.31pershareayearago,representinganearningssurpriseof12.500.31 per share a year ago, representing an earnings surprise of 12.50% [1] - The company posted revenues of 3.5 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 2%, but down from 3.66billionyearoveryear[2]Overthelastfourquarters,AdienthassurpassedconsensusEPSestimatesthreetimesandtoppedconsensusrevenueestimatestwotimes[2]FutureOutlookThesustainabilityofAdientsstockpricemovementwilldependonmanagementscommentaryduringtheearningscallandtheearningsoutlookforthecomingquarters[3][4]ThecurrentconsensusEPSestimateforthenextquarteris3.66 billion year-over-year [2] - Over the last four quarters, Adient has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Future Outlook - The sustainability of Adient's stock price movement will depend on management's commentary during the earnings call and the earnings outlook for the coming quarters [3][4] - The current consensus EPS estimate for the next quarter is 0.33 on revenues of 3.47billion,andforthecurrentfiscalyear,itis3.47 billion, and for the current fiscal year, it is 1.93 on revenues of $14.24 billion [7] - The estimate revisions trend for Adient is currently unfavorable, resulting in a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Industry Context - The Automotive - Original Equipment industry, to which Adient belongs, is currently in the bottom 29% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Adient's performance [5]